Maralixibat in Patients With Cystic Fibrosis and Constipation
NCT06413368
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Constipation Chronic Idiopathic
Cystic Fibrosis
Interventions
DRUG:
Maralixibat 9.5 MG/ML [Livmarli]
Sponsor
Children's Hospital Los Angeles